Amalgamated Bank’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,409
| Closed | -$1K | – | 3083 |
|
|
2025
Q1 | $1K | Hold |
2,409
| – | – | ﹤0.01% | 2917 |
|
|
2024
Q4 | $2K | Hold |
2,409
| – | – | ﹤0.01% | 2909 |
|
|
2024
Q3 | $4K | Hold |
2,409
| – | – | ﹤0.01% | 2827 |
|
|
2024
Q2 | $4K | Hold |
2,409
| – | – | ﹤0.01% | 2862 |
|
|
2024
Q1 | $6K | Sell |
2,409
-7,538
| -76% | -$16.2K | ﹤0.01% | 2653 |
|
|
2023
Q4 | $15K | Sell |
9,947
-717
| -7% | -$853 | ﹤0.01% | 2767 |
|
|
2023
Q3 | $12K | Hold |
10,664
| – | – | ﹤0.01% | 2858 |
|
|
2023
Q2 | $24K | Buy |
10,664
+1,553
| +17% | +$4.12K | ﹤0.01% | 2653 |
|
|
2023
Q1 | $22K | Sell |
9,111
-1,926
| -17% | -$4.41K | ﹤0.01% | 2609 |
|
|
2022
Q4 | $21K | Hold |
11,037
| – | – | ﹤0.01% | 2738 |
|
|
2022
Q3 | $26K | Buy |
11,037
+1,113
| +11% | +$3.08K | ﹤0.01% | 2731 |
|
|
2022
Q2 | $18K | Buy |
9,924
+303
| +3% | +$578 | ﹤0.01% | 2880 |
|
|
2022
Q1 | $20K | Sell |
9,621
-683
| -7% | -$1.89K | ﹤0.01% | 2810 |
|
|
2021
Q4 | $41K | Sell |
10,304
-149
| -1% | -$724 | ﹤0.01% | 2115 |
|
|
2021
Q3 | $50K | Sell |
10,453
-415
| -4% | -$1.7K | ﹤0.01% | 2133 |
|
|
2021
Q2 | $50K | Buy |
+10,868
| New | +$52.3K | ﹤0.01% | 2163 |
|
|
2015
Q2 | – | Sell |
-3,131
| Closed | -$21K | – | 1371 |
|
|
2015
Q1 | $21K | Buy |
3,131
+13
| +0.4% | +$89 | ﹤0.01% | 930 |
|
|
2014
Q4 | $20K | Buy |
3,118
+204
| +7% | +$1.64K | ﹤0.01% | 853 |
|
|
2014
Q3 | $29K | Buy |
2,914
+11
| +0.4% | +$117 | ﹤0.01% | 835 |
|
|
2014
Q2 | $33K | Sell |
2,903
-250
| -8% | -$2.69K | 0.01% | 865 |
|
|
2014
Q1 | $38K | Sell |
3,153
-16
| -0.5% | -$204 | 0.01% | 826 |
|
|
2013
Q4 | $40K | Buy |
+3,169
| New | +$50.4K | 0.01% | 828 |
|
Other funds holding LXRX
AG
SL
SSA
SC
GCP
